ApicHope Pharmaceutical Balance Sheet Health
Financial Health criteria checks 5/6
ApicHope Pharmaceutical has a total shareholder equity of CN¥2.7B and total debt of CN¥1.1B, which brings its debt-to-equity ratio to 42.7%. Its total assets and total liabilities are CN¥4.7B and CN¥2.0B respectively. ApicHope Pharmaceutical's EBIT is CN¥263.9M making its interest coverage ratio -360.9. It has cash and short-term investments of CN¥605.4M.
Key information
42.7%
Debt to equity ratio
CN¥1.15b
Debt
Interest coverage ratio | -360.9x |
Cash | CN¥605.41m |
Equity | CN¥2.69b |
Total liabilities | CN¥1.96b |
Total assets | CN¥4.65b |
Financial Position Analysis
Short Term Liabilities: 300723's short term assets (CN¥1.6B) exceed its short term liabilities (CN¥1.6B).
Long Term Liabilities: 300723's short term assets (CN¥1.6B) exceed its long term liabilities (CN¥395.4M).
Debt to Equity History and Analysis
Debt Level: 300723's net debt to equity ratio (20.2%) is considered satisfactory.
Reducing Debt: 300723's debt to equity ratio has increased from 0.04% to 42.7% over the past 5 years.
Debt Coverage: 300723's debt is well covered by operating cash flow (41.7%).
Interest Coverage: 300723 earns more interest than it pays, so coverage of interest payments is not a concern.